市場調査レポート

商品コード

1520615

開発業務受託機関（CRO）サービスの世界市場の評価：タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

CRO Services Market Assessment, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年07月25日
発行: Market Xcel - Markets and Data
ページ情報: 英文 221 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 646,065円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 818,349円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,177,274円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の開発業務受託機関（CRO）サービスの市場規模は、2023年の700億7,000万米ドルから2031年に1,359億1,000万米ドルに達すると予測され、2024年～2031年の予測期間にCAGRで8.63％の成長が見込まれます。さまざまな要因が市場を形成しており、それには技術強化への注力の高まり、拡大に向け資金を確保している企業、臨床研究サービスに対する需要の増加、がんにおける利用の増加、欧州市場の成長、M&Aの増加などが含まれます。

市場は技術の採用の進行によって成長しています。CROは、臨床試験を変革する革新的な技術の導入で業界をリードしています。CROは、AI、機械学習、クラウドコンピューティングの融合により、手順を最適化し、データアナリティクスを改善し、よりよい意思決定を行うことができるようになりました。この技術革命により、CROは顧客に先進の効果的なデータ主導型のサービスを提供できるようになっています。CROは、バイオテクノロジーや製薬部門の変化する需要に対応するため、提供するサービスを多様化しています。CROは、希少疾患、細胞・遺伝子治療、実臨床エビデンスの作成といった新しい分野に特化したサービスを提供しています。多様化することで、CROはライバルと一線を画し、拡大する世界の開発業務受託機関（CRO）サービス市場でより大きなシェアを獲得することができます。

さまざまな患者集団や規制当局の状況にアクセスするため、CROはグローバルフットプリントを構築しています。同時に、現地市場の需要に合わせたサービスを提供し、現地の法律や慣習が遵守されるようにしています。このようなグローバル戦略により、CROはどこでも統一された品質基準を維持しながら、顧客にカスタマイズされたソリューションを提供できるようになり、世界の開発業務受託機関（CRO）サービス市場の成長につながっています。CROは、研究参加者の安全性と臨床試験データの正確性を保証するため、規制遵守と品質管理システムを優先しています。強力なデータ管理手続きを導入し、厳格な品質管理手続きを採用し、規制機関と緊密に連携しています。世界の開発業務受託機関（CRO）サービス市場において、その名声を維持し、スポンサーの商取引を繰り返し獲得するために、CROは品質とコンプライアンスへの専念を堅持しなければなりません。

例えば、バイオメトリックCROのQuanticate International Ltd.は2024年4月、スポンサーがアダプティブ試験を設計し最適化するのを支援する新サービスを導入するため、臨床試験向けソフトウェアを開発する機械学習企業のPhaseV Trials Ltd.と提携したことを発表しました。両社はPhaseVの機械学習プラットフォームとソフトウェアを、Quanticateの統計プログラミング、生物統計学、臨床データ管理ソリューションと組み合わせ、Quanticateの統計コンサルタントがスポンサーの臨床試験がアダプティブデザインに適しているかどうかを判断できる新しいシステムを構築することを目指しています。中間データに応じてデザインを適応させる臨床試験は、アダプティブ試験として知られています。

市場における技術強化への注目の高まり

世界の開発業務受託機関（CRO）サービス市場は、業界の成長を加速させる大きな技術的転換を迎えています。臨床試験の複数の分野を向上させるために、CROはワークフローにAIやMLを使用するようになってきています。AI主導のプラットフォームは、患者の募集を改善し、安全性に関する警告をより迅速に特定し、実臨床エビデンスをより効率的に提供する可能性を秘めています。これにより、CROは顧客に先進のデータ主導型のサービスを提供できるようになります。データの保存、分析、管理を向上させるため、CROはクラウドベースのソリューションに移行しつつあります。臨床試験において、より効率的なデータ処理、チームワークの強化、情報に基づいた意思決定が可能になります。

当レポートでは、世界の開発業務受託機関（CRO）サービス市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

市場規模と予測
- 金額
タイプ別
- 初期段階開発サービス
- 臨床研究サービス
- ラボラトリーサービス
- コンサルティングサービス
- データ管理サービス
用途別
- 腫瘍
- 心臓
- 神経
- 感染症
- 代謝障害
- 腎臓
- その他
エンドユーザー別
- 製薬企業、バイオテクノロジー企業
- 医療機器企業
- 研究所、学術機関
- その他
地域別
- 北米
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
市場シェア：企業別（2023年）

第5章世界の開発業務受託機関（CRO）サービス市場の見通し：地域別（2017年～2031年）

北米
- 市場規模と予測
- タイプ別
- 用途別
- エンドユーザー別
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- イタリア
- 英国
- ロシア
- オランダ
- スペイン
- トルコ
- ポーランド
アジア太平洋
- インド
- 中国
- 日本
- オーストラリア
- ベトナム
- 韓国
- インドネシア
- フィリピン
南米
- ブラジル
- アルゼンチン
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ

第6章市場マッピング（2023年）

タイプ別
用途別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需給分析
輸入輸出分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因（課題、抑制要因）

第9章規制枠組みとイノベーション

イノベーション/新技術

第10章主要企業の情勢

マーケットリーダー上位5社の競合マトリクス
マーケットリーダー上位5社の市場収益の分析（2023年）
合併と買収/合弁事業（該当する場合）
SWOT分析（市場企業5社）
特許分析（該当する場合）

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

Charles River Laboratories Inc.
Iqvia Holdings Inc.
Parexel International Corporation
PRA Health Sciences
WuXi AppTec Group
Syneos Health, Inc.
Laboratory Corporation of America Holdings
PPD, Inc.
ICON plc
Medpace Holdings, Inc.

第14章戦略的推奨

第15章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global CRO Services Market Share (%), By Type, 2017-2031F
Figure 3. Global CRO Services Market Share (%), By Application, 2017-2031F
Figure 4. Global CRO Services Market Share (%), By End-user, 2017-2031F
Figure 5. Global CRO Services Market Share (%), By Region, 2017-2031F
Figure 6. North America CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 7. North America CRO Services Market Share (%), By Type, 2017-2031F
Figure 8. North America CRO Services Market Share (%), By Application, 2017-2031F
Figure 9. North America CRO Services Market Share (%), By End-user, 2017-2031F
Figure 10. North America CRO Services Market Share (%), By Country, 2017-2031F
Figure 11. United States CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 12. United States CRO Services Market Share (%), By Type, 2017-2031F
Figure 13. United States CRO Services Market Share (%), By Application, 2017-2031F
Figure 14. United States CRO Services Market Share (%), By End-user, 2017-2031F
Figure 15. Canada CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 16. Canada CRO Services Market Share (%), By Type, 2017-2031F
Figure 17. Canada CRO Services Market Share (%), By Application, 2017-2031F
Figure 18. Canada CRO Services Market Share (%), By End-user, 2017-2031F
Figure 19. Mexico CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 20. Mexico CRO Services Market Share (%), By Type, 2017-2031F
Figure 21. Mexico CRO Services Market Share (%), By Application, 2017-2031F
Figure 22. Mexico CRO Services Market Share (%), By End-user, 2017-2031F
Figure 23. Europe CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 24. Europe CRO Services Market Share (%), By Type, 2017-2031F
Figure 25. Europe CRO Services Market Share (%), By Application, 2017-2031F
Figure 26. Europe CRO Services Market Share (%), By End-user, 2017-2031F
Figure 27. Europe CRO Services Market Share (%), By Country, 2017-2031F
Figure 28. Germany CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 29. Germany CRO Services Market Share (%), By Type, 2017-2031F
Figure 30. Germany CRO Services Market Share (%), By Application, 2017-2031F
Figure 31. Germany CRO Services Market Share (%), By End-user, 2017-2031F
Figure 32. France CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 33. France CRO Services Market Share (%), By Type, 2017-2031F
Figure 34. France CRO Services Market Share (%), By Application, 2017-2031F
Figure 35. France CRO Services Market Share (%), By End-user, 2017-2031F
Figure 36. Italy CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 37. Italy CRO Services Market Share (%), By Type, 2017-2031F
Figure 38. Italy CRO Services Market Share (%), By Application, 2017-2031F
Figure 39. Italy CRO Services Market Share (%), By End-user, 2017-2031F
Figure 40. United Kingdom CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 41. United Kingdom CRO Services Market Share (%), By Type, 2017-2031F
Figure 42. United Kingdom CRO Services Market Share (%), By Application, 2017-2031F
Figure 43. United Kingdom CRO Services Market Share (%), By End-user, 2017-2031F
Figure 44. Russia CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 45. Russia CRO Services Market Share (%), By Type, 2017-2031F
Figure 46. Russia CRO Services Market Share (%), By Application, 2017-2031F
Figure 47. Russia CRO Services Market Share (%), By End-user, 2017-2031F
Figure 48. Netherlands CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 49. Netherlands CRO Services Market Share (%), By Type, 2017-2031F
Figure 50. Netherlands CRO Services Market Share (%), By Application, 2017-2031F
Figure 51. Netherlands CRO Services Market Share (%), By End-user, 2017-2031F
Figure 52. Spain CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 53. Spain CRO Services Market Share (%), By Type, 2017-2031F
Figure 54. Spain CRO Services Market Share (%), By Application, 2017-2031F
Figure 55. Spain CRO Services Market Share (%), By End-user, 2017-2031F
Figure 56. Turkey CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 57. Turkey CRO Services Market Share (%), By Type, 2017-2031F
Figure 58. Turkey CRO Services Market Share (%), By Application, 2017-2031F
Figure 59. Turkey CRO Services Market Share (%), By End-user, 2017-2031F
Figure 60. Poland CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 61. Poland CRO Services Market Share (%), By Type, 2017-2031F
Figure 62. Poland CRO Services Market Share (%), By Application, 2017-2031F
Figure 63. Poland CRO Services Market Share (%), By End-user, 2017-2031F
Figure 64. South America CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 65. South America CRO Services Market Share (%), By Type, 2017-2031F
Figure 66. South America CRO Services Market Share (%), By Application, 2017-2031F
Figure 67. South America CRO Services Market Share (%), By End-user, 2017-2031F
Figure 68. South America CRO Services Market Share (%), By Country, 2017-2031F
Figure 69. Brazil CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 70. Brazil CRO Services Market Share (%), By Type, 2017-2031F
Figure 71. Brazil CRO Services Market Share (%), By Application, 2017-2031F
Figure 72. Brazil CRO Services Market Share (%), By End-user, 2017-2031F
Figure 73. Argentina CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 74. Argentina CRO Services Market Share (%), By Type, 2017-2031F
Figure 75. Argentina CRO Services Market Share (%), By Application, 2017-2031F
Figure 76. Argentina CRO Services Market Share (%), By End-user, 2017-2031F
Figure 77. Asia-Pacific CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 78. Asia-Pacific CRO Services Market Share (%), By Type, 2017-2031F
Figure 79. Asia-Pacific CRO Services Market Share (%), By Application, 2017-2031F
Figure 80. Asia-Pacific CRO Services Market Share (%), By End-user, 2017-2031F
Figure 81. Asia-Pacific CRO Services Market Share (%), By Country, 2017-2031F
Figure 82. India CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 83. India CRO Services Market Share (%), By Type, 2017-2031F
Figure 84. India CRO Services Market Share (%), By Application, 2017-2031F
Figure 85. India CRO Services Market Share (%), By End-user, 2017-2031F
Figure 86. China CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 87. China CRO Services Market Share (%), By Type, 2017-2031F
Figure 88. China CRO Services Market Share (%), By Application, 2017-2031F
Figure 89. China CRO Services Market Share (%), By End-user, 2017-2031F
Figure 90. Japan CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 91. Japan CRO Services Market Share (%), By Type, 2017-2031F
Figure 92. Japan CRO Services Market Share (%), By Application, 2017-2031F
Figure 93. Japan CRO Services Market Share (%), By End-user, 2017-2031F
Figure 94. Australia CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 95. Australia CRO Services Market Share (%), By Type, 2017-2031F
Figure 96. Australia CRO Services Market Share (%), By Application, 2017-2031F
Figure 97. Australia CRO Services Market Share (%), By End-user, 2017-2031F
Figure 98. Vietnam CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 99. Vietnam CRO Services Market Share (%), By Type, 2017-2031F
Figure 100. Vietnam CRO Services Market Share (%), By Application, 2017-2031F
Figure 101. Vietnam CRO Services Market Share (%), By End-user, 2017-2031F
Figure 102. South Korea CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 103. South Korea CRO Services Market Share (%), By Type, 2017-2031F
Figure 104. South Korea CRO Services Market Share (%), By Application, 2017-2031F
Figure 105. South Korea CRO Services Market Share (%), By End-user, 2017-2031F
Figure 106. Indonesia CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 107. Indonesia CRO Services Market Share (%), By Type, 2017-2031F
Figure 108. Indonesia CRO Services Market Share (%), By Application, 2017-2031F
Figure 109. Indonesia CRO Services Market Share (%), By End-user, 2017-2031F
Figure 110. Philippines CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 111. Philippines CRO Services Market Share (%), By Type, 2017-2031F
Figure 112. Philippines CRO Services Market Share (%), By Application, 2017-2031F
Figure 113. Philippines CRO Services Market Share (%), By End-user, 2017-2031F
Figure 114. Middle East & Africa CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 115. Middle East & Africa CRO Services Market Share (%), By Type, 2017-2031F
Figure 116. Middle East & Africa CRO Services Market Share (%), By Application, 2017-2031F
Figure 117. Middle East & Africa CRO Services Market Share (%), By End-user, 2017-2031F
Figure 118. Middle East & Africa CRO Services Market Share (%), By Country, 2017-2031F
Figure 119. Saudi Arabia CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 120. Saudi Arabia CRO Services Market Share (%), By Type, 2017-2031F
Figure 121. Saudi Arabia CRO Services Market Share (%), By Application, 2017-2031F
Figure 122. Saudi Arabia CRO Services Market Share (%), By End-user, 2017-2031F
Figure 123. UAE CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 124. UAE CRO Services Market Share (%), By Type, 2017-2031F
Figure 125. UAE CRO Services Market Share (%), By Application, 2017-2031F
Figure 126. UAE CRO Services Market Share (%), By End-user, 2017-2031F
Figure 127. South Africa CRO Services Market, By Value, In USD Billion, 2017-2031F
Figure 128. South Africa CRO Services Market Share (%), By Type, 2017-2031F
Figure 129. South Africa CRO Services Market Share (%), By Application, 2017-2031F
Figure 130. South Africa CRO Services Market Share (%), By End-user, 2017-2031F
Figure 131. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 132. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11637

Global contract research organization (CRO) services market is projected to witness a CAGR of 8.63% during the forecast period 2024-2031F, growing from USD 70.07 billion in 2023 to USD 135.91 billion in 2031F. Various factors shape the global CRO services market, including an increased focus on technological enhancements, companies securing funding for expansion, increased demand for clinical research services, a rise in applications in oncology, a growing European market, and increasing mergers and acquisitions.

The global CRO services market is growing because of the increasing adoption of technology. CROs are leading the way in implementing innovative technologies to transform clinical trials. CROs are better positioned to optimize procedures, improve data analysis, and make better decisions thanks to the convergence of artificial intelligence, machine learning, and cloud computing. Due to this technological revolution, CROs can now offer their clients more advanced, effective, and data-driven services. CROs are diversifying their offerings to meet the changing demands of the biotech and pharmaceutical sectors. They provide specialized services in new fields such as rare diseases, cell and gene therapies, and the creation of real-world evidence. By diversifying, CROs can set themselves apart from rivals and take a bigger chunk of the expanding global CRO services market.

To access a variety of patient populations and regulatory contexts, CROs are creating a global footprint. Simultaneously, they are tailoring their offerings to suit the local market's demands and ensuring that local laws and customs are followed. With the help of this global strategy, CROs can provide their clients with customized solutions while upholding uniform quality standards everywhere, leading to growth in the global CRO services market. CROs are prioritizing regulatory compliance and quality management systems to guarantee research participant safety and the accuracy of clinical trial data. They are putting strong data management procedures into place, employing strict quality control procedures, and working closely with regulatory bodies. To keep their good name and win sponsors' recurring business in the global CRO services market, CROs must remain steadfast in their dedication to quality and compliance.

For example, to introduce a new service that intends to assist sponsors in designing and optimizing adaptive trials, biometric CRO Quanticate International Ltd. announced in April 2024 that it has partnered with PhaseV Trials Ltd., a machine learning firm that develops software for clinical trials. The companies aim to combine PhaseV's machine learning platform and software with Quanticate's statistical programming, biostatistics, and clinical data management solutions to create a new system that will enable Quanticate's statistical consultants to determine whether a sponsor's trial is appropriate for an adaptive design. Clinical trials that adapt their designs in response to interim data are known as adaptive trials.

Increased Focus on Technological Enhancements in the Market

The global CRO services market is undergoing a major technological transition that is accelerating the growth in the industry. To improve several areas of clinical trials, CROs are increasingly using AI and ML in their workflows. AI-driven platforms have the potential to improve patient recruitment, identify safety warnings more quickly, and provide real-world evidence more efficiently. This makes it possible for CROs to offer their clients more advanced, data-driven services. To improve data storage, analytics, and management, CROs are moving to cloud-based solutions. During clinical trials, this enables more effective data processing, enhanced teamwork, and more informed decision-making.

For example, the global oncology research leader, Sarah Cannon Research Institute (SCRI), which conducts community-based clinical trials, announced in February 2024 that it is partnering with AstraZeneca Plc, a science-led biopharmaceutical company, to advance innovative technology and operational synergies to improve oncology clinical trial delivery. Together, AstraZeneca and SCRI will put cutting-edge strategies into practice to improve U.S. recruitment, lessen site burden, and expedite clinical trial delivery schedules.

Companies are Securing Funding for Expansion in the Market

Various companies in the industry are securing funds to grow in the global CRO services market. CROs are using funding to diversify the services and skills they offer. This enables them to address a greater variety of client needs in various therapeutic domains and phases of the medication development process. CROs are making investments in the integration of cutting-edge technology, such as cloud computing, machine learning, and artificial intelligence. As a result, their clinical trial services are more accurate, efficient, and data driven. Funding is being used by CROs to establish specialized teams and infrastructure aimed at therapeutic domains, like oncology, illnesses of the central nervous system, and uncommon diseases. Their subject experience makes them more appealing as partners to clients in the biotech and pharmaceutical industries.

For example, Manifold Inc., a clinical research platform driven by artificial intelligence, obtained USD 15 million in series A funding in April 2024 to form alliances with healthcare institutions. TQ Ventures led the investment round. With the Series A funding, Manifold intends to expand its collaborations with cancer centers and other healthcare institutions and make investments in research and development to add new features and capabilities.

Increased Demand for Clinical Research Services in the Market

There are several factors responsible for the high demand for clinical research services in the global CRO services market. The increased prevalence of chronic diseases like cardiovascular diseases, cancer, etc., has increased the importance of clinical research studies. Clinical research studies aid in the growth of evidence-based medicine, which helps medical professionals make more educated treatment decisions. The development of precision or personalized medicine, in which patient traits are considered while designing therapies, is aided by clinical research. Due to the treatments' improved fit for the patient's genetic profile, lifestyle, and other pertinent variables, this strategy may result in more potent therapies with fewer adverse effects.

For instance, Medidata Solutions Inc., a provider of clinical trial data solutions, extended its long-term agreement with Pharmaceutical Product Development (PPD), Thermo Fisher Scientific Inc.'s clinical research organization, in February 2024. The agreement reaffirms their continuous co-development of PPD TrueCast, an artificial intelligence solution for clinical trials, and permits the CRO to continue using Medidata's core platform. Medidata has established a valuable relationship with the PPD clinical research industry to improve visibility and decision-making during clinical trials.

Rising Application in Oncology is Driving Market Growth

Many CROs have acquired specific knowledge and experience in managing clinical trials related to cancer. They have assembled specialized groups of clinicians, scientists, and support personnel who are committed to addressing the difficulties associated with cancer research. CROs frequently have a deep network of established connections with community-based and academic clinical trial sites spread throughout numerous areas. This enables them to conduct cancer research on a variety of patient populations. To increase the effectiveness and caliber of oncology clinical trials, CROs are making investments in cutting-edge technology, including artificial intelligence, digital data management platforms, and remote monitoring tools. All these factors make oncology an important subject of the industry, driving the growth of the global CRO services market.

For instance, Harvest Integrated Research Organization (HiRO), a cutting-edge international contract research organization (CRO) with headquarters in China, announced in September 2023 that it has successfully acquired Courante Oncology, a full-service clinical research provider with headquarters in the US that specializes in oncology product development. HiRO's acquisition of Courante Oncology is a big step in the right direction as it works to establish itself as a major worldwide CRO. With increased capabilities and a stronger presence in the US, HiRO is well positioned to provide its clients with cutting-edge, quick clinical trial solutions anywhere in the world.

European Region to Grow Exponentially in the Forecast Period

It is anticipated that the CRO services market will grow exponentially in the European region in the future, driving the overall growth of the global CRO services market. The growing incidence of chronic diseases, rising healthcare costs, and the trend towards outsourcing clinical research operations are all contributing to the growth of the European clinical trials market. To take advantage of the growing demand for their services, CROs are being drawn to strengthen their presence in Europe as a result of this growing market opportunity. It is becoming simpler for CROs to conduct business in several European nations due to the harmonization of clinical trial laws throughout the continent, which is made possible by programs like the Clinical Trials Regulation (CTR) in the European Union.

For example, the acquisition of Heads Research, a privately held European contract research organization (CRO) that specializes in cancer clinical trials, was announced in March 2024 by Veeda Clinical Research Limited, a full-service CRO with a track record of success in drug development. With this acquisition, Veeda joins the elite group of international contract research organizations (CROs) that offer comprehensive capabilities to provide contract research services ranging from post-commercial launch to clinical development and discovery.

Future Market Scenario (2024-2031F)

The global CRO services market is growing because CROs are expanding their specialized knowledge and skills into therapeutic domains other than cancer, such as cell and gene therapies, uncommon illnesses, and central nervous system disorders.

It is anticipated that the global CRO services market will continue to grow because many CROs plan to implement decentralized and hybrid clinical trial models.

It is expected that the global CRO services market will grow because Environmental, social, and governance (ESG) concepts and sustainability are being integrated by CROs more and more into their commercial operations.

CROs are fortifying their position in these areas like Asia, Latin America and Africa to grow in the global CRO services market and take advantage of the rising demand for clinical research services in the emerging markets.

Key Players Landscape and Outlook

The global CRO services market has observed many mergers and acquisitions in recent times. Smaller, more niche CROs are being bought out by larger CROs to diversify their offerings. This enables them to provide their clientele with a more complete range of solutions. The larger CROs can obtain new technology and methods or acquire experience in particular therapeutic areas, like cancer, by acquiring niche players. Through acquisitions, larger CROs can enter new markets and extend their geographic reach. This is especially crucial as the global market for clinical trials expands. In addition to giving larger CROs a footing in new markets, smaller CROs with a strong local or regional presence can help them service customers more efficiently across many locations.

For example, American Clinical Research Services (ACRS), a renowned multi-specialty clinical research network with operations spanning Florida, Massachusetts, Michigan, and Missouri, successfully acquired Elixia Tech Solutions Ltd. in May 2024. ACRS is a leader in complex clinical research and was founded by Latticework Capital Management (LCM). Elixia's collaboration with ACRS strengthens their shared dedication to furthering research in difficult therapeutic areas. Through this combination, it will be able to launch and maintain studies that have the potential to significantly improve patient outcomes, as well as increase site capabilities and resources.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global CRO Services Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
4.2. By Type
- 4.2.1. Early Phase Development Services
  - 4.2.1.1. Preclinical Services
    - 4.2.1.1.1. Pharmacokinetics/Pharmacodynamics Services
    - 4.2.1.1.2. Toxicology Testing Services
    - 4.2.1.1.3. Other Preclinical Services
  - 4.2.1.2. Chemistry, Manufacturing and Control Services
  - 4.2.1.3. Discovery Studies
- 4.2.2. Clinical Research Services
  - 4.2.2.1. By Study Design
    - 4.2.2.1.1. Real World Evidence (RWE)
    - 4.2.2.1.2. Interventional
  - 4.2.2.2. By Phase
    - 4.2.2.2.1. Phase I
    - 4.2.2.2.2. Phase II
    - 4.2.2.2.3. Phase III
    - 4.2.2.2.4. Phase IV
- 4.2.3. Laboratory Services
- 4.2.4. Consulting Services
- 4.2.5. Data Management Services
4.3. By Application
- 4.3.1. Oncology
- 4.3.2. Cardiology
- 4.3.3. Neurology
- 4.3.4. Infectious Diseases
- 4.3.5. Metabolic Disorders
- 4.3.6. Nephrology
- 4.3.7. Others
4.4. By End-user
- 4.4.1. Pharmaceutical and Biotechnological Companies
- 4.4.2. Medical Device Companies
- 4.4.3. Research Laboratories and Academic Institutes
- 4.4.4. Others
4.5. By Region
- 4.5.1. North America
- 4.5.2. Europe
- 4.5.3. Asia-Pacific
- 4.5.4. South America
- 4.5.5. Middle East and Africa
4.6. By Company Market Share (%), 2023

5. Global CRO Services Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
- 5.1.2. By Type
  - 5.1.2.1. Clinical Research Services
    - 5.1.2.1.1. By Study Design
      - 5.1.2.1.1.1. Real World Evidence (RWE)
      - 5.1.2.1.1.2. Interventional
    - 5.1.2.1.2. By Phase
      - 5.1.2.1.2.1. Phase I
      - 5.1.2.1.2.2. Phase II
      - 5.1.2.1.2.3. Phase III
      - 5.1.2.1.2.4. Phase IV
  - 5.1.2.2. Early Phase Development Services
    - 5.1.2.2.1. Preclinical Services
      - 5.1.2.2.1.1. Pharmacokinetics/Pharmacodynamics Services
      - 5.1.2.2.1.2. Toxicology Testing Services
      - 5.1.2.2.1.3. Other Preclinical Services
    - 5.1.2.2.2. Chemistry, Manufacturing and Control Services
    - 5.1.2.2.3. Discovery Studies
  - 5.1.2.3. Laboratory Services
  - 5.1.2.4. Consulting Services
  - 5.1.2.5. Data Management Services
- 5.1.3. By Application
  - 5.1.3.1. Oncology
  - 5.1.3.2. Cardiology
  - 5.1.3.3. Neurology
  - 5.1.3.4. Infectious Diseases
  - 5.1.3.5. Metabolic Disorders
  - 5.1.3.6. Nephrology
  - 5.1.3.7. Others
- 5.1.4. By End-user
  - 5.1.4.1. Pharmaceutical and Biotechnological Companies
  - 5.1.4.2. Medical Device Companies
  - 5.1.4.3. Research Laboratories and Academic Institutes
  - 5.1.4.4. Others
- 5.1.5. United States*
  - 5.1.5.1. Market Size & Forecast
    - 5.1.5.1.1. By Value
  - 5.1.5.2. By Type
    - 5.1.5.2.1. Clinical Research Services
      - 5.1.5.2.1.1. By Study Design
      - 5.1.5.2.1.1.1. Real World Evidence (RWE)
      - 5.1.5.2.1.1.2. Interventional
      - 5.1.5.2.1.2. By Phase
      - 5.1.5.2.1.2.1. Phase I
      - 5.1.5.2.1.2.2. Phase II
      - 5.1.5.2.1.2.3. Phase III
      - 5.1.5.2.1.2.4. Phase IV
    - 5.1.5.2.2. Early Phase Development Services
      - 5.1.5.2.2.1. Preclinical Services
      - 5.1.5.2.2.1.1. Pharmacokinetics/Pharmacodynamics Services
      - 5.1.5.2.2.1.2. Toxicology Testing Services
      - 5.1.5.2.2.1.3. Other Preclinical Services
      - 5.1.5.2.2.2. Chemistry, Manufacturing and Control Services
      - 5.1.5.2.2.3. Discovery Studies
    - 5.1.5.2.3. Laboratory Services
    - 5.1.5.2.4. Consulting Services
    - 5.1.5.2.5. Data Management Services
  - 5.1.5.3. By Application
    - 5.1.5.3.1. Oncology
    - 5.1.5.3.2. Cardiology
    - 5.1.5.3.3. Neurology
    - 5.1.5.3.4. Infectious Diseases
    - 5.1.5.3.5. Metabolic Disorders
    - 5.1.5.3.6. Nephrology
    - 5.1.5.3.7. Others
  - 5.1.5.4. By End-User
    - 5.1.5.4.1. Pharmaceutical and Biotechnological Companies
    - 5.1.5.4.2. Medical Device Companies
    - 5.1.5.4.3. Research Laboratories and Academic Institutes
    - 5.1.5.4.4. Others
- 5.1.6. Canada
- 5.1.7. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East and Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Type
6.2. By Application
6.3. By End-user
6.4. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat From New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Charles River Laboratories Inc.
13.2. Iqvia Holdings Inc.
- 13.2.1. Company Details
- 13.2.2. Key Management Personnel
- 13.2.3. Products and Services
- 13.2.4. Financials (As Reported)
- 13.2.5. Key Market Focus and Geographical Presence
- 13.2.6. Recent Developments
13.3. Parexel International Corporation
13.4. PRA Health Sciences
13.5. WuXi AppTec Group
13.6. Syneos Health, Inc.
13.7. Laboratory Corporation of America Holdings
13.8. PPD, Inc.
13.9. ICON plc
13.10. Medpace Holdings, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

開発業務受託機関（CRO）サービスの世界市場の評価：タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

CRO Services Market Assessment, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の開発業務受託機関（CRO）サービス市場の見通し（2017年～2031年）

第5章世界の開発業務受託機関（CRO）サービス市場の見通し：地域別（2017年～2031年）

第6章市場マッピング（2023年）

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的推奨

第15章当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global CRO Services Market Outlook, 2017-2031F

5. Global CRO Services Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

開発業務受託機関（CRO）サービスの世界市場の評価：タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

CRO Services Market Assessment, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の開発業務受託機関（CRO）サービス市場の見通し（2017年～2031年）

第5章 世界の開発業務受託機関（CRO）サービス市場の見通し：地域別（2017年～2031年）

第6章 市場マッピング（2023年）

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的推奨

第15章 当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global CRO Services Market Outlook, 2017-2031F

5. Global CRO Services Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の開発業務受託機関（CRO）サービス市場の見通し（2017年～2031年）

第5章世界の開発業務受託機関（CRO）サービス市場の見通し：地域別（2017年～2031年）

第6章市場マッピング（2023年）

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的推奨

第15章当社について、免責事項